Bonus Biogroup Showcased Breakthrough Trial Results at International Drug Development Seminar at the invitation of Jackson Laboratory, USA. Bonus Biogroup is delighted to announce the successful preclinical demonstration [1] of MesenCure's effectiveness in treating lethal toxicity induced by chemotherapy drugs, such as Cisplatin and Bleomycin, routinely used in cancer treatment.…